Covid: Pfizer asks FDA for approval of vaccine for five

Pfizer has formally asked the US Food and Drug Administration (FDA) for authorisation of its Covid vaccine for Americans aged five to 11.

If approved, the shot could become available within weeks and boost the number of Americans immunised against Covid.

The pharmaceutical firm found in trials that children should receive a third of the dose given to adults.

Thursday’s announcement follows pressure from parents for vaccinations to open up for school age children, most of whom have returned to classrooms for the first time in a year.

An expert panel will publicly debate the evidence from Pfizer’s trials on 26 October, with a final decision likely not long after.

Pfizer said in a series of tweets that it had “officially submitted our request to US FDA for Emergency Use Authorisation (EUA) of our Covid vaccine in children 5 to

“With new cases in children in the US continuing to be at a high level, this submission is an important step in our ongoing effort against Covid”.

“We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat.”

More follows

Read More

Mel B reveals she’s still recovering from Covid after five weeks: ‘Covid is no joke’

Anti-vaxxer killed pharmacist brother and sister-in-law for ‘killing people’ with the Covid shot

Joe Biden says he’s changed his mind on the death penalty. Why isn’t he doing more to stop it?

Sage Steele: ESPN host pulled off air in rant about Barack Obama’s race and vaccine mandates

Pfizer enlists entire town in Brazil to study ongoing efficacy of its Covid vaccine

Reference Article

RELATED POST